SCHEMBL6287816

SCHEMBL6287816

Cc1cn2nc(-c3ccccc3)c(N)c2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 2/20 0.39
KDM4E B2RXH2 8/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
USP2 O75604 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ATM Q13315 2/20 0.38
MAPK1 P28482 1/20 0.38
ALDH1A1 P00352 5/20 0.37
HPGD P15428 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
RAB9A P51151 4/20 0.37
NPC1 O15118 3/20 0.37
GAA P10253 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MAPT P10636 3/20 0.36
TDP1 Q9NUW8 1/20 0.36
GLA P06280 2/20 0.36
LMNA P02545 1/20 0.36
AKT2 P31751 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6283492 0.83 MASP2 (0.39) XDHKDM4EKMT2AMEN1USP2
SCHEMBL6279512 0.81 KDM4E (0.37) XDHKDM4EKMT2AMEN1USP2
SCHEMBL6288020 0.73 KDM4E (0.41) XDHKDM4EKMT2AMEN1ATM
SCHEMBL6288495 0.72 RAB9A (0.40) KDM4EKMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL6279830 0.71 KDM4E (0.39) XDHKDM4EKMT2AMEN1USP2
SCHEMBL6283289 0.68 MASP2 (0.40) KDM4EKMT2AMEN1ALDH1A1HPGD
SCHEMBL6287241 0.67 KDM4E (0.45) XDHKDM4EKMT2AALDH1A1HPGD
SCHEMBL6288030 0.67 ALDH1A1 (0.38) XDHKDM4EKMT2AMEN1USP2
SCHEMBL13860397 0.66 CDK8 (0.50) KDM4EKMT2AMEN1L3MBTL1MAPK1
SCHEMBL2268955 0.66 KDM4E (0.47) KDM4EKMT2AMEN1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923929-B1 KERATIN FIBRE DYE COMPOSITION CONTAINING PYRAZOLO-AZOLE COMPOUNDS, USE THEREOF AS OXIDATION AGENTS, AND DYEING METHOD; PYRAZOLOAZOLES OREAL (FR) 2004-05-12 EP claimed
US-20020152558-A1 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles L'OREAL 2002-10-24 US claimed
US-6379397-B2 CAPABLE OF GENERATING INTENSE COLORINGS IN VARIED SHADES L'OREAL S.A. (FR) 2002-04-30 US claimed
US-6855827-B2 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles L'ORÉAL (FR) 2005-02-15 US disclosed
US-20020152558-A1 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles L'OREAL 2002-10-24 US disclosed
US-6379397-B2 CAPABLE OF GENERATING INTENSE COLORINGS IN VARIED SHADES L'OREAL S.A. (FR) 2002-04-30 US disclosed
US-20020007520-A1 COMPOSITIONS FOR DYEING KERATINOUS FIBERS COMPRISING PYRAZOLOAZOLES; THEIR USE IN DYEING AS OXIDATION BASE AND DYEING PROCESS; AND NOVEL PYRAZOLOAZOLES L'OREAL S.A. (FR) 2002-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007520-A1 COMPOSITIONS FOR DYEING KERATINOUS FIBERS COMPRISING PYRAZOLOAZOLES; THEIR USE IN DYEING AS OXIDATION BASE AND DYEING PROCESS; AND NOVEL PYRAZOLOAZOLES KRT18, ZYX, TUBB3 XDH 222/4885KDM4E 1907/4885KMT2A 1852/4885
US-20020152558-A1 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles KRT18, ZYX, TUBB3 XDH 222/4885KDM4E 1907/4885KMT2A 1852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.